Skip to main content
. 2014 Dec 15;1(12):844–853. doi: 10.18632/oncoscience.106

Figure 1. Sunitinib treatment of HT-29PAR and HT-29SUN tumors.

Figure 1

(A) and (B) Growth curves of tumors established from HT-29 parental (HT-29PAR) (A) and HT-29 sunitinib resistant (HT-29SUN) (B) tumor cells after tumor cell injection (5×106 cells; n = 6). Mice received treatment with vehicle or sunitinib malate (40 mg/kg/day). (C) and (D) Tumor weights at the end of the experiment of HT-29PAR (C) and HT-29SUN (D) tumors. Results are shown as mean ± SEM (n = 6); ***, P < 0.001, NS= not significant.